Alvarado-Esquivel C, Sifuentes-Álvarez A, Estrada-Martínez S, Rojas-Rivera A

Language: Spanish
References: 29
Page: 311-324
PDF size: 107.36 Kb.

ABSTRACT

Objectives: To determine the level of knowledge and practices about toxoplasmosis in physicians attending pregnant women in Durango, Mexico. Materials and methods: One hundred physicians attending pregnant women in Durango, Mexico were surveyed. Of them, 67 were general practitioners, 17 family physicians, and 16 obstetricians. They were asked about (i) the parasite Toxoplasma gondii; (ii) general aspects about toxoplasmosis including clinical manifestations, diagnosis, treatment, and epidemiology; and (iii) their practices and experiences on toxoplasmosis. Results: From 66 to 89% (mean 78.5%) of physicians answered correctly about the parasite; 25 to 63% (mean 46.9%) answered correctly about clinical manifestations; and 36 to 45% (mean 40.5%) answered correctly about the serological diagnosis. Only 7% knew about the use of avidity test. Few physicians (23%) knew what medicaments are used against toxoplasmosis. From 12 to 86% (mean 40.3%) of participants answered correctly about transmission routes and only 7% got the right answer about susceptibility of infection. Fifty-nine percent of physicians never requested laboratory tests for detecting toxoplasmosis, and only 31% provide information for preventing infection to all their patients. Sixteen (16%) physicians had detected at least one case of Toxoplasma infection acquired during pregnancy. Conclusions: The physicians surveyed showed an incomplete knowledge about diagnosis and treatment of toxoplasmosis. Results are useful for optimal design of strategies in the medical education about toxoplasmosis.

REFERENCES

1. Hill DE, Chirukandoth S, Dubey JP. Biology and epidemiology of Toxoplasma gondii in man and animals. Anim Health Res Rev. 2005;6:41-61.

2. Montoya JG, Liesenfeld O. Toxoplasmosis. Lancet. 2004;363:1965-76.

3. Kravetz JD, Federman DG. Toxoplasmosis in pregnancy. Am J Med. 2005;118:212-6.

4. Rorman E, Zamir CS, Rilkis I, Ben-David H. Congenital toxoplasmosisprenatal aspects of Toxoplasma gondii infection. Reprod Toxicol. 2006;21:458-72.

5. Pleyer U, Torun N, Liesenfeld O. Ocular toxoplasmosis. Ophthalmologe. 2007;104:603-15.

6. Swisher CN, Boyer K, McLeod R. Congenital toxoplasmosis. The Toxoplasmosis Study Group. Semin Pediatr Neurol. 1994;1:4-25.

7. Montoya JG, Remington JS. Management of Toxoplasma gondii infection during pregnancy. Clin Infect Dis. 2008;47:554-66.

8. Dubey JP. Toxoplasmosis of animals and humans. Second Edition. Florida: CRC Press, Boca Raton; 2009.

9. Dubey JP. Toxoplasmosis - a waterborne zoonosis. Vet Parasitol. 2004;126:57-72.

10. Dawson D. Foodborne protozoan parasites. Int J Food Microbiol. 2005;103:207-27.

11. Barsoum RS. Parasitic infections in transplant recipients. Nat Clin Pract Nephrol. 2006;2:490-503.

12. Figueroa Damian R. Risk of transmission of infectious diseases by transfusion. Ginecol Obstet Mex. 1998;66:277-83.

13. Wurzner R. Transplantation-associated infections. Verh Dtsch Ges Pathol. 2004;88:85-8.

14. Jones J, López A, Wilson M. Congenital toxoplasmosis. Am Fam Physician. 2003;67:2131-8.

15. Vela-Amieva M, Cañedo-Solares I, Gutiérrez-Castrellón P, et al. Short report: neonatal screening pilot study of Toxoplasma gondii congenital infection in Mexico. Am J Trop Med Hyg. 2005;72:142-4.

16. Jones JL, Dietz VJ, Power M, et al. Survey of obstetrician-gynecologists in the United States about toxoplasmosis. Infect Dis Obstet Gynecol. 2001;9:23-31.

17. Kravetz JD, Federman DG. Prevention of toxoplasmosis in pregnancy: knowledge of risk factors. Infect Dis Obstet Gynecol. 2005;13:161-5.

18. Jones JL, Krueger A, Schulkin J, Schantz PM. Toxoplasmosis prevention and testing in pregnancy, survey of obstetrician-gynaecologists. Zoonoses Public Health. 2010;57:27-33.

19. Remington JS, McLeod R, Thulliez P, Desmonts G. Toxoplasmosis. En: Remington JS, Klein JO, eds. Infectious diseases of the fetus and newborn. 5th ed. Filadelfia: WB Saunders, 2001. p. 205-346.

20. Petersen E. Toxoplasmosis. Semin Fetal Neonatal Med. 2007;12:214-23.

21. Alvarado-Esquivel C, Sethi S, Janitschke K, Hahn H, Liesenfeld O. Comparison of two commercially available avidity tests for Toxoplasmaspecific IgG antibodies. Arch Med Res. 2002;33:520-3.

22. Petersen E, Borobio MV, Guy E, et al. European multicenter study of the LIAISON automated diagnostic system for determination of Toxoplasma gondii-specific immunoglobulin G (IgG) and IgM and the IgG avidity index. J Clin Microbiol. 2005;43:1570-4.

23. Alvarado-Esquivel C, Sifuentes-Álvarez A, Narro-Duarte SG, et al. Seroepidemiology of Toxoplasma gondii infection in pregnant women in a public hospital in northern Mexico. BMC Infect Dis. 2006;6:113.

24. Alvarado-Esquivel C, Alanis-Quiñones OP, Arreola-Valenzuela MA, et al. Seroepidemiology of Toxoplasma gondii infection in psychiatric inpatients in a northern Mexican city. BMC Infect Dis. 2006;6:178.

25. Alvarado-Esquivel C, Cruz-Magallanes HM, Esquivel-Cruz R, et al. Seroepidemiology of Toxoplasma gondii infection in human adults from three rural communities in Durango State, Mexico. J Parasitol. 2008;94:811-6.

26. Alvarado-Esquivel C, Liesenfeld O, Torres-Castorena A, et al. Seroepidemiology of Toxoplasma gondii infection in patients with vision and hearing impairments, cancer, HIV, or undergoing hemodialysis in Durango, Mexico. J Parasitol. 2010;96:505-8.

27. Alvarado-Esquivel C, Rojas-Rivera A, Estrada-Martínez S, et al. Seroepidemiology of Toxoplasma gondii infection in a Mennonite community in Durango State, Mexico. J Parasitol. 2010;96:941-5.

28. Alvarado-Esquivel C, Torres-Castorena A, Liesenfeld O, et al. Seroepidemiology of Toxoplasma gondii infection in pregnant women in rural Durango, Mexico. J Parasitol. 2009;95:271-4.

29. Galván Ramírez M de la L, Soto Mancilla JL, Velasco Castrejón O, Pérez Medina R. Incidence of anti-Toxoplasma antibodies in women with high-risk pregnancy and habitual abortions. Rev Soc Bras Med Trop. 1995;28:333-7.